Clinical Trial Update: Ipilimumab + Androgen Depravation Therapy in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on ipilimumab combined with androgen deprivation therapy in prostate cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• ipilimumab (ipilimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-10-09